Homegrown COVID-19 pill gets regulatory approval
By Wang Xiaoyu |
chinadaily.com.cn |
Updated: 2022-07-25 19:48
Share
Share - WeChat
China's top drug regulator said on Monday it has granted conditional approval for a homegrown oral pill to be used to treat COVID-19.
Azvudine, developed by Genuine Biotech Co Ltd based in Henan province, was first approved to treat HIV/AIDS patients on July 20 last year, according to the National Medical Products Administration.
The approval clears the way for the pill to be used for adults with moderate COVID-19 symptoms, the administration said in a notice released on its official website.
- BRI annual Chinese character unveiled in SW China's Chongqing
- Hunan's Huaihua promotes its cultural cuisine
- Confucius' hometown celebrates the philosopher's birth anniversary
- China approves first Chikungunya virus detection kit
- Fujian Coast Guard organizes fleets to strengthen law enforcement patrols
- China re-elected as Category One member by global civil aviation body
